Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,735
Closed -$218K 261
2025
Q4
$218K Sell
1,735
-264
-13% -$34.4K 0.03% 220
2025
Q3
$292K Sell
1,999
-72
-3% -$10.9K 0.04% 183
2025
Q2
$323K Buy
2,071
+158
+8% +$25.1K 0.05% 175
2025
Q1
$315K Buy
1,913
+132
+7% +$22K 0.06% 174
2024
Q4
$290K Buy
1,781
+11
+0.6% +$1.97K 0.05% 180
2024
Q3
$346K Buy
+1,770
New +$326K 0.06% 164
2024
Q1
Sell
-1,068
Closed -$211K 256
2023
Q4
$211K Buy
+1,068
New +$189K 0.06% 223

Other funds holding ZTS

Oarsman Capital's ZTS Position: Q1 2026 in Review

Oarsman Capital sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 1,735 shares — an estimated $218K sold.

Oarsman Capital first reported a position in ZTS in Q4 2023 and held it in 7 quarters. The position peaked at $346K in Q3 2024. 1,614 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Oarsman Capital reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Oarsman Capital sold 1,735 Zoetis shares in Q1 2026, an estimated $218K.
  • Oarsman Capital first reported a position in Zoetis in Q4 2023 and held it in 7 quarters.
  • Oarsman Capital's Zoetis position peaked at $346K in Q3 2024.
  • 1,614 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.